Cancer Research CR 2010 Workshops
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arnett-Mansfield, R. L.
Right arrow Articles by Clarke, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arnett-Mansfield, R. L.
Right arrow Articles by Clarke, C. L.
[Cancer Research 61, 4576-4582, June 1, 2001]
© 2001 American Association for Cancer Research

Tumor Biology

Relative Expression of Progesterone Receptors A and B in Endometrioid Cancers of the Endometrium1

Rebecca L. Arnett-Mansfield, Anna deFazio, Gerard V. Wain, Richard C. Jaworski, Karen Byth, Patricia A. Mote and Christine L. Clarke2

Westmead Institute for Cancer Research, University of Sydney at the Westmead Millenium Institute, [R. L. A-M., A. deF., P. A. M., C. L. C.], and Departments of Gynaecological Oncology [A. deF., G. V. W.], Tissue Pathology [R. C. J.], and Medicine [K. B.], Westmead Hospital, Westmead, New South Wales 2145, Australia

The nuclear receptor for the female hormone progesterone (PR) is widely expressed in uterine cancer. PR is expressed as two proteins (PRA and PRB) with different functions, and in vitro evidence reveals PRA to inhibit PRB function, so the cellular ratio of PRA:PRB is likely to be an important determinant of progesterone action. The relative expression of PRA and B and their involvement in the pathogenesis of endometrial cancer is not known. The aims of this study were to determine PRA and B expression by dual immunofluorescent histochemistry in endometrial adenocarcinomas compared with expression in normal and hyperplastic glands, and to correlate expression in tumors with clinical features including grade. Significantly lower PR levels were found in tumors compared with normal glands and areas of complex atypical hyperplasia within the same specimen. The normal glands expressed both of the isoforms at similar levels, whereas there was increased predominance of one isoform in hyperplastic areas and in tumors, which suggested that the loss of coordinated expression of PR isoforms was an early event in tumor progression. The majority of tumors [27 (58%) of 46] expressed only one PR isoform, and the proportion expressing either PRA or B was the same [14 (30%) of 46, and 13 (28%) of 46, respectively]. One-half of all tumors ([23 (50%) of 46] expressed either PRA only or a predominance of PRA, and a few tumors [10 (22%) of 46] expressed comparable levels of PRA and B. Similar levels of PRA and B were noted only in FIGO grade 1 tumors, whereas higher grades (2 and 3) were associated with a predominance of one isoform. In summary, expression of only one PR isoform was common in endometrial cancers, which indicates that the decreased PR levels observed in these cancers arise from the loss of one PR isoform. Expression of a single PR isoform was associated with higher clinical grade, which suggests a relationship between the loss of PR isoform expression and features of poorer prognosis. Disruption of relative PR isoform expression was observed in complex atypical hyperplasia, which suggests that early alterations in the ratio of PRA:PRB may precede and/or be implicated in the development of endometrial adenocarcinoma. Alterations in the ratio of PR isoform expression are likely to cause disordered regulation of target genes, resulting in altered progestin action in the uterus, and this may be involved in the pathogenesis of endometrial cancer.




This article has been cited by other articles:


Home page
 Endocr Relat CancerHome page
P. Chaudhry and E. Asselin
Resistance to chemotherapy and hormone therapy in endometrial cancer
Endocr. Relat. Cancer, June 1, 2009; 16(2): 363 - 380.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
F. De Amicis, S. Zupo, M. L. Panno, R. Malivindi, F. Giordano, I. Barone, L. Mauro, S. A. W. Fuqua, and S. Ando
Progesterone Receptor B Recruits a Repressor Complex to a Half-PRE Site of the Estrogen Receptor {alpha} Gene Promoter
Mol. Endocrinol., April 1, 2009; 23(4): 454 - 465.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
M.C. Fleisch, Y.C. Chou, R. D. Cardiff, A. Asaithambi, and G. Shyamala
Overexpression of progesterone receptor A isoform in mice leads to endometrial hyperproliferation, hyperplasia and atypia
Mol. Hum. Reprod., April 1, 2009; 15(4): 241 - 249.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
E. C. Ward, A. V. Hoekstra, L. J. Blok, P. Hanifi-Moghaddam, J. R. Lurain, D. K. Singh, B. M. Buttin, J. C. Schink, and J. J. Kim
The Regulation and Function of the Forkhead Transcription Factor, Forkhead Box O1, Is Dependent on the Progesterone Receptor in Endometrial Carcinoma
Endocrinology, April 1, 2008; 149(4): 1942 - 1950.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
F. M. Horne and D. L. Blithe
Progesterone receptor modulators and the endometrium: changes and consequences
Hum. Reprod. Update, November 1, 2007; 13(6): 567 - 580.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
R. L. Arnett-Mansfield, J. D. Graham, A. R. Hanson, P. A. Mote, A. Gompel, L. L. Scurr, N. Gava, A. de Fazio, and C. L. Clarke
Focal Subnuclear Distribution of Progesterone Receptor Is Ligand Dependent and Associated with Transcriptional Activity
Mol. Endocrinol., January 1, 2007; 21(1): 14 - 29.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. C. Hewitt
The Five W's of Progesterone Receptors A and B: Now We Know Where and When.
Endocrinology, December 1, 2006; 147(12): 5501 - 5502.
[Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
J.-H. Man, H.-Y. Li, P.-J. Zhang, T. Zhou, K. He, X. Pan, B. Liang, A.-L. Li, J. Zhao, W.-L. Gong, et al.
PIAS3 induction of PRB sumoylation represses PRB transactivation by destabilizing its retention in the nucleus
Nucleic Acids Res., November 14, 2006; 34(19): 5552 - 5566.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. C. Velarde, M. Iruthayanathan, R. R. Eason, D. Zhang, F. A. Simmen, and R. C. M. Simmen
Progesterone Receptor Transactivation of the Secretory Leukocyte Protease Inhibitor Gene in Ishikawa Endometrial Epithelial Cells Involves Recruitment of Kruppel-Like Factor 9/Basic Transcription Element Binding Protein-1
Endocrinology, April 1, 2006; 147(4): 1969 - 1978.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. S. Huggins, J. Y.Y. Wong, S. E. Hankinson, and I. De Vivo
GATA5 Activation of the Progesterone Receptor Gene Promoter in Breast Cancer Cells Is Influenced by the +331G/A Polymorphism
Cancer Res., February 1, 2006; 66(3): 1384 - 1390.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. D. Graham, M. L. Yager, H. D. Hill, K. Byth, G. M. O'Neill, and C. L. Clarke
Altered Progesterone Receptor Isoform Expression Remodels Progestin Responsiveness of Breast Cancer Cells
Mol. Endocrinol., November 1, 2005; 19(11): 2713 - 2735.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
P.B. Marshburn, J. Zhang, Z.B. Mostafavi, M.L. Matthews, J. White, and B.S. Hurst
Variant progesterone receptor mRNAs are co-expressed with the wild-type progesterone receptor mRNA in human endometrium during all phases of the menstrual cycle
Mol. Hum. Reprod., November 1, 2005; 11(11): 809 - 815.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. A. Belinsky, D. M. Klinge, J. D. Dekker, M. W. Smith, T. J. Bocklage, F. D. Gilliland, R. E. Crowell, D. D. Karp, C. A. Stidley, and M. A. Picchi
Gene Promoter Methylation in Plasma and Sputum Increases with Lung Cancer Risk
Clin. Cancer Res., September 15, 2005; 11(18): 6505 - 6511.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
P. E. Schwartz
Progesterone Isoforms and Endometrial Cancer
Reproductive Sciences, May 1, 2005; 12(4): 219 - 221.
[PDF]

Home page
 Reproductive SciencesHome page
E. E. Hanekamp, S. C.J.P. Gielen, P. E. De Ruiter, S. Chadha-Ajwani, F. J. Huikeshoven, C. W. Burger, J. A. Grootegoed, and L. J. Blok
Differences in Invasive Capacity of Endometrial Cancer Cell Lines Expressing Different Progesterone Receptor Isotypes: Possible Involvement of Cadherins
Reproductive Sciences, May 1, 2005; 12(4): 278 - 284.
[Abstract] [PDF]

Home page
 Reproductive SciencesHome page
E. Smid-Koopman, L. C. M. Kuhne, E. E. Hanekamp, S. C.J.P. Gielen, P. E. De Ruiter, J. A. Grootegoed, T. J.M. Helmerhorst, C. W. Burger, A. O. Brinkmann, F. J. Huikeshoven, et al.
Progesterone-Induced Inhibition of Growth and Differential Regulation of Gene Expression in PRA- and/or PRB-Expressing Endometrial Cancer Cell Lines
Reproductive Sciences, May 1, 2005; 12(4): 285 - 292.
[Abstract] [PDF]

Home page
 Hum Reprod UpdateHome page
N. Chabbert-Buffet, G. Meduri, P. Bouchard, and I. M. Spitz
Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications
Hum. Reprod. Update, May 1, 2005; 11(3): 293 - 307.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
D. Dai, L. Albitar, T. Nguyen, L. L. Laidler, M. Singh, and K. K. Leslie
A therapeutic model for advanced endometrial cancer: Systemic progestin in combination with local adenoviral-mediated progesterone receptor expression
Mol. Cancer Ther., January 1, 2005; 4(1): 169 - 175.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
E. E Hanekamp, L. M Kuhne, J A. Grootegoed, C. W Burger, and L. J Blok
Progesterone receptor A and B expression and progestagen treatment in growth and spread of endometrial cancer cells in nude mice
Endocr. Relat. Cancer, December 1, 2004; 11(4): 831 - 841.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Sumida, Y. Itahana, H. Hamakawa, and P.-Y. Desprez
Reduction of Human Metastatic Breast Cancer Cell Aggressiveness on Introduction of Either Form A or B of the Progesterone Receptor and Then Treatment with Progestins
Cancer Res., November 1, 2004; 64(21): 7886 - 7892.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
B. Mulac-Jericevic and O. M Conneely
Reproductive tissue selective actions of progesterone receptors
Reproduction, August 1, 2004; 128(2): 139 - 146.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. L. Arnett-Mansfield, A. deFazio, P. A. Mote, and C. L. Clarke
Subnuclear Distribution of Progesterone Receptors A and B in Normal and Malignant Endometrium
J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1429 - 1442.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
A. Vienonen, S. Miettinen, M. Blauer, P. M. Martikainen, E. Tomas, P. K. Heinonen, and T. Ylikomi
Expression of Nuclear Receptors and Cofacotrs in Human Endometrium and Myometrium
Reproductive Sciences, February 1, 2004; 11(2): 104 - 112.
[Abstract] [PDF]

Home page
 Clin. Cancer Res.Home page
E. E. Hanekamp, S. C. J. P. Gielen, E. Smid-Koopman, L. C. M. Kuhne, P. E. de Ruiter, S. Chadha-Ajwani, A. O. Brinkmann, J. A. Grootegoed, C. W. Burger, F. J. Huikeshoven, et al.
Consequences of Loss of Progesterone Receptor Expression in Development of Invasive Endometrial Cancer
Clin. Cancer Res., September 15, 2003; 9(11): 4190 - 4199.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X.-L. Zhang, D. Zhang, F. J. Michel, J. L. Blum, F. A. Simmen, and R. C. M. Simmen
Selective Interactions of Kruppel-like Factor 9/Basic Transcription Element-binding Protein with Progesterone Receptor Isoforms A and B Determine Transcriptional Activity of Progesterone-responsive Genes in Endometrial Epithelial Cells
J. Biol. Chem., June 6, 2003; 278(24): 21474 - 21482.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
E. Smid-Koopman, L. J. Blok, L. C. M. Kuhne,, C. W. Burger, T. J. M. Helmerhorst, A. O. Brinkman, and F. J. Huikeshoven
Distinct Functional Differences of Human Progesterone Receptors A and B on Gene Expression and Growth Regulation in Two Endometrial Carcinoma Cell Lines
Reproductive Sciences, January 1, 2003; 10(1): 49 - 57.
[Abstract] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
I. De Vivo, G. S. Huggins, S. E. Hankinson, P. J. Lescault, M. Boezen, G. A. Colditz, and D. J. Hunter
A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk
PNAS, September 17, 2002; 99(19): 12263 - 12268.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Abdel-Hafiz, G. S. Takimoto, L. Tung, and K. B. Horwitz
The Inhibitory Function in Human Progesterone Receptor N Termini Binds SUMO-1 Protein to Regulate Autoinhibition and Transrepression
J. Biol. Chem., September 6, 2002; 277(37): 33950 - 33956.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
P A Mote, J F Johnston, T Manninen, P Tuohimaa, and C L Clarke
Detection of progesterone receptor forms A and B by immunohistochemical analysis
J. Clin. Pathol., August 1, 2001; 54(8): 624 - 630.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.